TY  - GEN
AU  - Villanueva-Paz, Marina
AU  - Niu, Hao
AU  - Segovia-Zafra, Antonio
AU  - Medina-Caliz, Inmaculada
AU  - Sanabria-Cabrera, Judith
AU  - Lucena, M. Isabel
AU  - Andrade, Raúl J.
AU  - Alvarez-Alvarez, Ismael
PY  - 2021
DO  - 10.3390/jcm10225317
UR  - http://hdl.handle.net/20.500.12105/18501
AB  - Drug-induced liver injury (DILI) encompasses the unexpected damage that drugs can cause to the liver. DILI may develop in the context of an immunoallergic syndrome with cutaneous manifestations, which are sometimes severe (SCARs). Nevirapine,...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - Drug-induced liver injury
KW  - Severe cutaneous adverse reactions
KW  - Hypersensitivity
KW  - Gaps
KW  - Causality assessment
KW  - Diagnosis
KW  - Management
KW  - Clinical trial
KW  - Immune response
KW  - Enfermedad hepática inducida por sustancias y drogas
KW  - Hipersensibilidad
KW  - Relaciones intergeneracionales
KW  - Diagnóstico
KW  - Ensayo clínico
KW  - Inmunidad
KW  - Allopurinol
KW  - Nevirapine
KW  - Alleles
KW  - Cicatrix
KW  - HLA-B Antigens
KW  - HLA-A Antigens
KW  - Prognosis
KW  - Sulfonamides
KW  - Anti-Bacterial Agents
KW  - Pharmaceutical Preparations, Dental
TI  - Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions
TY  - review article
ER  -